Curis, Inc.
Curis, Inc. (CRIS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRIS · as of Jun 8, 2026
Key Statistics
Explore Curis, Inc. Data
cris stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 88.9%
Competitors & Peers
cris competitorsCRIS
ASBP
ATHA
BCTX
CTXR
ENTOStock Performance
Full HistoryAbout Curis, Inc.
Curis, Inc. is a biotechnology firm dedicated to identifying and advancing therapeutic compounds for various human cancers across the United States. Its current clinical-stage pipeline features Emavus…
what is curis, inc. · cris stock overview · curis, inc. company profile · who is curis, inc. ceo · cris NASDAQ · curis, inc. headquarters · curis, inc. business segments
About Stock Overview & Key Data
Curis, Inc. (CRIS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 1, 2000. As of the latest trading session, CRIS stock price is $0.47, with a market capitalization of $6.2M. The stock has returned -80.81% over the past 12 months and -52.38% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Curis, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Curis, Inc. reported revenue of $9.4M and net income of -$7.6M. For detailed data — including Curis, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Curis, Inc. (CRIS) stock price is $0.47. The stock is traded on NASDAQ under the ticker symbol CRIS. The 52-week range is $0.46 – $3.13.